Literature DB >> 15040427

The irreversibly sickled cell: a perspective.

S R Goodman1.   

Abstract

The irreversibly sickled cell (ISC) is poorly deformable, dehydrated, of short life span, correlated to hemolysis, and a contributor to the pathophysiology of vaso-occlusive (VOC) episodes. The altered redox status and increased oxygen radical levels within high density sickle cells leads to oxidative damage and glutathiolation of cysteine residues. The formation of a disulfide bridge between Cys 284 and Cys 373 in ISC beta-actin leads to actin filaments which depolymerize poorly at 37 degrees C. Glutathiolation of cysteines within spectrin results in this key membrane skeletal protein losing it's E2/E3 ubiquitin-ligating/conjugating activity and therefore ability to self ubiquitinate. The resulting loss of ubiquitination in ISC alpha-spectrin repeats 20/21 causes a higher affinity ISC spectrin-4.1-actin ternary complex. Therefore, reversible oxidative damage to beta-actin and loss of ubiquitination of alpha-spectrin leads to an ISC membrane skeleton that disassembles poorly at 37 degrees C. The result is a membrane skeleton which is "locked" because it cannot disassemble or reassemble. N-acetylcysteine (NAC) is an antioxidant which raises intracellular reduced glutathione levels, and blocks the formation of ISCs in vitro. NAC, in a phase II human trial, caused a downward trend in ISCs, significantly decreased dense cells, and substantially decreased the rate of VOC episodes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15040427

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  11 in total

1.  Diverse protective roles of the actin cytoskeleton during oxidative stress.

Authors:  Michelle E Farah; Vladimir Sirotkin; Brian Haarer; David Kakhniashvili; David C Amberg
Journal:  Cytoskeleton (Hoboken)       Date:  2011-06-10

Review 2.  Spectrin's chimeric E2/E3 enzymatic activity.

Authors:  Steven R Goodman; Rachel Petrofes Chapa; Warren E Zimmer
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

Review 3.  L-glutamine for sickle cell disease: Knight or pawn?

Authors:  Alina Sadaf; Charles T Quinn
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-27

4.  Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes.

Authors:  Tennille D Presley; Andreas S Perlegas; Lauren E Bain; Samir K Ballas; James S Nichols; Hernan Sabio; Mark T Gladwin; Gregory J Kato; Daniel B Kim-Shapiro
Journal:  Hemoglobin       Date:  2010       Impact factor: 0.849

5.  Insights into determinants of spleen injury in sickle cell anemia.

Authors:  Sara El Hoss; Sylvie Cochet; Mickaël Marin; Claudine Lapouméroulie; Michael Dussiot; Naïm Bouazza; Caroline Elie; Mariane de Montalembert; Cécile Arnaud; Corinne Guitton; Béatrice Pellegrino; Marie Hélène Odièvre; Frédérique Moati; Caroline Le Van Kim; Yves Colin Aronovicz; Wassim El Nemer; Valentine Brousse
Journal:  Blood Adv       Date:  2019-08-13

6.  Electrical Impedance Characterization of Erythrocyte Response to Cyclic Hypoxia in Sickle Cell Disease.

Authors:  Jia Liu; Yuhao Qiang; Ofelia Alvarez; E Du
Journal:  ACS Sens       Date:  2019-05-23       Impact factor: 7.711

Review 7.  The proteome of sickle cell disease: insights from exploratory proteomic profiling.

Authors:  Susan Yuditskaya; Anthony F Suffredini; Gregory J Kato
Journal:  Expert Rev Proteomics       Date:  2010-12       Impact factor: 3.940

8.  Conserved actin cysteine residues are oxidative stress sensors that can regulate cell death in yeast.

Authors:  Michelle E Farah; David C Amberg
Journal:  Mol Biol Cell       Date:  2007-02-07       Impact factor: 4.138

9.  The effect of xanthine oxidase and hypoxanthine on the permeability of red cells from patients with sickle cell anemia.

Authors:  Halima W M Al Balushi; David C Rees; John N Brewin; Anke Hannemann; John S Gibson
Journal:  Physiol Rep       Date:  2018-03

Review 10.  Oxidative stress in β-thalassaemia and sickle cell disease.

Authors:  S Voskou; M Aslan; P Fanis; M Phylactides; M Kleanthous
Journal:  Redox Biol       Date:  2015-08-01       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.